AMRN FY 2018 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$229M+26.6% YoY

Gross Profit

$175M76.2% margin

Operating Income

-$108M-47.2% margin

Net Income

-$116M-50.8% margin

EPS (Diluted)

$-7.80

Cash Flow

Operating Cash Flow

-$95M

Free Cash Flow

-$95M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$386M

Total Liabilities

$233M

Stockholders' Equity

$152M

Cash & Equivalents

$249M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$229M	$181M	+26.6%
Gross Profit	$175M	$136M	+28.3%
Operating Income	-$108M	-$46M	-137.6%
Net Income	-$116M	-$68M	-71.6%